Microt Co., Ltd. is an ophthalmic medical device bio-venture company established in 2019 as an in-house venture of Samsung Medical Center. We specialize in the localization of ocular valve implants for Minimally Invasive Glaucoma Surgery (MIGS) and the development of ophthalmology-related healthcare products. Based on the clinical experience of practicing ophthalmologists and precision machining technology, we are leading the domestic and international ophthalmic medical device market.

"We pursue innovation that can provide practical help to medical staff and patients in the field, and we aim to improve the quality of life for patients around the world by providing safe and reliable alternatives for glaucoma treatment."

Business Areas

• Ophthalmic Medical Device Research and Manufacturing: We research and manufacture implants and ophthalmic surgical equipment for minimally invasive glaucoma surgery that effectively and safely control intraocular pressure in glaucoma patients. Based on ultra-precision micro-tubing technology, we are increasing the standardization and convenience of high-difficulty ophthalmic surgeries.
• Eye Care Healthcare Solutions: We develop and supply functional cleansers and eye health supplements for the prevention of ophthalmic diseases and eyelid hygiene management. We provide total eye care solutions based on ophthalmic clinical practice, such as optic nerve management and eyelid hygiene.

Products

• A-stream: An ocular valve implant for minimally invasive glaucoma surgery that combines ultra-small silicone tube and detachable guide stent (Ripcord) technology. It is a Class 3 medical device approved by the Ministry of Food and Drug Safety that prevents early postoperative hypotony complications and maximizes the predictability of long-term intraocular pressure control.
• Cleaneol: A pad-type eye cleansing product developed for hygienic management of eyelids and eyelashes. It uses tea tree-derived ingredients to help manage the cleanliness of sensitive skin around the eyes and the meibomian glands.
• Maxnamin: A high-content Vitamin B3 (nicotinamide)-based powder stick health functional food that helps protect the optic nerve and promote eye health.

Special Notes

• Innovative R&D Capabilities Based on Clinical Specialists: Developed based on the clinical experience of the CEO, who is an ophthalmologist at Samsung Medical Center, we precisely address unmet needs in actual surgical settings. We have secured proprietary Ripcord patent technology that lowers the risk of complications and entry barriers for existing high-difficulty glaucoma surgeries.
• Entry into Big 5 Hospitals and Global Scalability: We have proven our clinical efficacy and safety through adoption in major domestic tertiary hospitals and thousands of cumulative surgical cases. Based on our achievements in the domestic market, we are accelerating our entry into the global market, including pursuing US FDA approval.

Recruitment Information

• Main Hiring Positions: Medical Device R&D, Clinical Research Associate (CRA), Global Business Development (BD), Marketing/PM, Quality Assurance/Quality Control (QA/QC)
• Benefits: 4 major social insurance, retirement pension, 5-day work week, annual/half-day/congratulatory and condolence leave, job skill improvement training and seminar support, congratulatory money, holiday gifts/bonuses, health checkups, snack and beverage support, parking and night transportation support

💡 A Word from JOBPLOY
Microt Co., Ltd. is a medical device bio-venture company leading the field of ultra-precision implants for glaucoma surgery. Due to the nature of the job, which requires compliance with precision machining technology and strict medical device quality regulations (GMP, ISO, etc.), meticulous work ability and an understanding of healthcare regulations are required. As the company is actively pursuing US FDA clinical trials and global market expansion, it can be a promising opportunity for foreign talent with global business capabilities and language skills. JOBPLOY recommends this company for those looking to grow in the global medical device sector.